Digital Pathology: Lagging or Leading?
Posted 4th May 2020 by Liv Sewell
When compared to traditional methods, digital pathology may seem totally superfluous, or interesting but not all that essential. And since the costs for the elegance of digital pathology solutions are not trivial in comparison to what the peddlers traditionally have offered, it is not surprising to see the adoption curve lagging. Where then is the ‘burning platform’ that can truly drive greater adoption of digital pathology?
Understanding the gut-liver axis: implications for NAFLD prevention and treatment
Posted 29th April 2020 by Liv Sewell
You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.
Automatic AI-powered Tumor Budding
Posted 27th April 2020 by Liv Sewell
Tumor Budding has been shown in numerous studies to be an independent prognostic factor in colorectal cancer (CRC) for the risk of distant metastasis and, in stage II CRC, for overall survival. Fraunhofer IIS and the Institute for Pathology, University Hospital Erlangen are developing an AI system to automatically detect tumor budding in CRC patients.
How to beneficially modulate vaginal microbiota to optimise women’s health
Posted 22nd April 2020 by Joshua Sewell
Each woman has a unique vaginal microbiota composition, which is dynamic and affected by diet, lifestyle, hormones, genetics, and age. In the past decade, exploration of the human microbiota has focused increasingly on vaginal microbiota composition and diversity and its impact on health, reproduction, and disease.
Digital Pathology in Drug Development: Opportunities and Challenges
Posted 20th April 2020 by Liv Sewell
We recently caught up with Dr Olulanu Aina, Scientific Director and Veterinary and Toxicological Pathologist at Janssen, about digital pathology applications in drug discovery...
Gut-brain axis insights: why the microbiota holds therapeutic potential for neuro-developmental disorders
Posted 17th April 2020 by Liv Sewell
Evidence is emerging that there are important connections between the gut microbiome and neurodevelopmental disorders. In a guest post for World Autism Awareness Month this April, Chris Kenji Beer reviews recent discoveries.
Probiotics save the gut microbiome from antibiotics
Posted 15th April 2020 by Joshua Sewell
Antibiotics consumption is increasing worldwide, yet these therapies not only destroy pathogens but also damage our vital intestinal flora.
Hafnia alvei HA4597™ – a new clinically validated solution in weight management
Posted 8th April 2020 by Joshua Sewell
Hyperphagia is a common underlying cause of overweight and obesity. However, the dieting approaches towards weight loss are usually ineffective due to a persistent increase in appetite. Most of the current products in weight management are based on the principle of sugar/fat blockers and binders which has proven to be rather short-term solution.
